Cargando…
Turicibacter and Acidaminococcus predict immune-related adverse events and efficacy of immune checkpoint inhibitor
INTRODUCTION: Immune checkpoint inhibitors have had a major impact on cancer treatment. Gut microbiota plays a major role in the cancer microenvironment, affecting treatment response. The gut microbiota is highly individual, and varies with factors, such as age and race. Gut microbiota composition i...
Autores principales: | Hamada, Kazuyuki, Isobe, Junya, Hattori, Kouya, Hosonuma, Masahiro, Baba, Yuta, Murayama, Masakazu, Narikawa, Yoichiro, Toyoda, Hitoshi, Funayama, Eiji, Tajima, Kohei, Shida, Midori, Hirasawa, Yuya, Tsurui, Toshiaki, Ariizumi, Hirotsugu, Ishiguro, Tomoyuki, Suzuki, Risako, Ohkuma, Ryotaro, Kubota, Yutaro, Sambe, Takehiko, Tsuji, Mayumi, Wada, Satoshi, Kiuchi, Yuji, Kobayashi, Shinichi, Kuramasu, Atsuo, Horiike, Atsushi, Kim, Yun-Gi, Tsunoda, Takuya, Yoshimura, Kiyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189048/ https://www.ncbi.nlm.nih.gov/pubmed/37207204 http://dx.doi.org/10.3389/fimmu.2023.1164724 |
Ejemplares similares
-
Case Report: Combined pembrolizumab, 5-fluorouracil, and cisplatin therapy were remarkably effective in p16-positive squamous cell carcinoma of unknown primary
por: Suzuki, Risako, et al.
Publicado: (2023) -
A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case report
por: Hamada, Kazuyuki, et al.
Publicado: (2022) -
Monocyte subsets associated with the efficacy of anti‑PD‑1 antibody monotherapy
por: Ohkuma, Ryotaro, et al.
Publicado: (2023) -
Verification of the Usefulness of an Assessment and Risk Control Sheet that Promotes Management of Cancer Drug Therapy
por: Honma, O., et al.
Publicado: (2022) -
‘Acidaminococcus timonensis’ sp. nov. and ‘Acidaminococcus massiliensis’ sp. nov. isolated from human gut
por: Ricaboni, D., et al.
Publicado: (2016)